March 24 - 25 2017


The Westin Philadelphia Philadelphia, Pennsylvania



Don't Miss Out. Register Now.

CME/CE Credit

Who Should Attend

This conference is designed for gastroenterologists, primary care physicians, advanced practice nurses, nurses, pharmacists, and physician assistants involved in the diagnosis, evaluation, management, and treatment of patients with digestive diseases.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Define Barrett’s esophagus and implement the appropriate treatment plan to achieve the desired clinical end point
  • Explain the clinical manifestations, treatment, and prognosis of esophageal cancer
  • Outline the pathogenesis, diagnosis and treatment of eosinophilic esophagitis
  • Discuss the risk-benefit ratio of proton pump inhibitors (PPIs)
  • Recognize the manifestations of celiac disease and use appropriate tests to identify the disease
  • Apply a multidisciplinary approach to treatment of celiac disease, combining the skills of the primary care physician, a gastroenterological specialist, the nutritionist, and a registered nurse
  • Compare treatment options available for the management of gastroparesis
  • Recognize the need for aggressive management of gastroduodenal ulcers in all patients as well as the appropriate role of PPIs to reduce the overuse of these agents
  • Describe the association between small intestinal bacterial overgrowth and various chronic conditions as well as the controversies surrounding the diagnosis and management of the condition
  • Recognize key clinical issues in bariatric surgery including patient selection criteria, risks and benefits, and peri- and post-operative management
  • Identify barriers to colorectal cancer screening and utilize appropriate strategies to identify and address these barriers
  • Differentiate irritable bowel syndrome (IBS) from other common gastrointestinal disorders
  • Describe new and emerging management strategies for IBS
  • Review the most current perspectives and clinical guidelines for the use of biologic agents in inflammatory bowel disease (IBD)
  • Incorporate a treatment approach for those patients with IBD that are difficult to treat
  • Assess optimal management strategies for patients with hepatic encephalopathy
  • Recognize, prevent, and treat fatty liver diseases, including nonalcoholic fatty liver disease and alcohol liver disease
  • Explain the cause, expected course of disease progression, and therapeutic options, including liver transplantation, for portopulmonary hypertension
  • Outline the diagnosis and treatment strategies for patients with hepatitis B
  • Evaluate the efficacy and safety of current and emerging therapeutic strategies for the treatment of hepatitis C virus (HCV)
  • Describe HCV risk factors and indications for screening and improve markers of patient care
  • Identify treatment choices for primary biliary cholangitis, including new treatment options, and be aware that treatment selection depends upon accurate evaluation of the stage of the disease
  • Apply the latest diagnostic tools for identifying hepatocellular carcinoma and select the best available therapeutic options for patients
  • Discuss the emerging paradigm for diagnosis and management of acute pancreatitis
  • Identify optimal strategies for identifying and managing gallstones and bile duct stones

Accreditation Statement

This activity has been planned and implemented by Rutgers Biomedical and Health Sciences and Global Academy for Medical Education. Rutgers Biomedical and Health Sciences is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This knowledge-based activity qualifies for 14.5 contact hours (1.45 CEUs) of continuing pharmacy education credit.

This activity is awarded 14.5 contact hours. (60 minute CH).

Nurses should only claim those contact hours actually spent participating in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 14.5 Category 1 credits for completing this activity.

Method of Participation

In order to meet the learning objectives and receive continuing education credits, participants are expected to check in at the registration desk both days, attend the program and complete the online evaluation at the conclusion of the program. A letter certifying attendance and credit verification will be emailed to participants upon completion of the online evaluation survey.

Faculty Disclosures

All individuals who affect the content of the continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made at the time of the activity.

Special Needs

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Please contact Global Academy for Medical Education at least 3 weeks in advance at 301.318.3489 or

Follow Us

Jointly Provided By